ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,238, issued on Sept. 29, was assigned to C4 THERAPEUTICS INC. (Watertown, Mass.).
"Selected compounds for targeted degradation of BRD9" was invented by Katrina L. Jackson (Weston, Mass.), Christopher G. Nasveschuk (Stoneham, Mass.), Rhamy Zeid (Arlington, Mass.), Ning Yin (Lexington, Mass.), Gesine Kerstin Veits (Somerville, Mass.), Moses Moustakim (Cambridge, Mass.), Jeremy L. Yap (Sudbury, Mass.), Minsheng He (Andover, Mass.), Robert T. Yu (Arlington, Mass.), Matthew J. Schnaderbeck (Methuen, Mass.), Kathleen Neville (Watertown, Mass.), Siyi Jiang (Watertown, Mass.), Meiqi Li (Watertown, Mass.), Qianwei Liu (Watertown, Mass.), Manjie Zheng (Watertown, Mass.), Jia Li (Watertown,...